| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $246K | -85.2% |
| Cost of Revenue | $128K | -90.2% |
| Gross Profit | $118K | -66.8% |
| R&D Expense | $354K | +88.7% |
| SG&A Expense | $10.6M | +56.5% |
| Operating Income | -$11.4M | -65.4% |
| Interest Expense | $5.0M | +194.3% |
| Pre-tax Income | -$17.4M | -64.5% |
| Income Tax | $0 | — |
| Net Income | -$17.4M | -64.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60K | -60.6% |
| Accounts Receivable | $5K | -95.1% |
| Inventory | $119K | +384.4% |
| Current Assets | $185K | -78.8% |
| Total Assets | $229K | -87.3% |
| Current Liabilities | $3.8M | +15.5% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.4M | -64.9% |
| Capital Expenditures | $25K | — |
| Investing Cash Flow | -$25K | — |
| Financing Cash Flow | $2.4M | +45.8% |
| Free Cash Flow | -$2.5M | -66.6% |
| Total Liabilities |
| $4.1M |
| -0.9% |
| Stockholders' Equity | -$3.9M | -64.7% |